Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Investing

Galan Declines AU$240M Bid for Argentina Projects

by admin April 4, 2025
April 4, 2025
Galan Declines AU$240M Bid for Argentina Projects

Galan Lithium (ASX:GLN) has rejected a US$150 million (AU$240 million) cash bid from China’s Zhejiang Huayou Cobalt Co and France’s Renault Group to acquire its Hombre Muerto West and Candelas lithium brine projects in Argentina, The West Australian reports.

Described as unsolicited, conditional, and non-binding, the offer from battery materials giant Zhejiang Huayou and EV manufacturer Renault was deemed “opportunistic” and “undervalued,” the report noted.

Galan and its advisors refused the offer, asserting confidence in the long-term value of its flagship Hombre Muerto West project, which is nearing production of 5,400 tonnes per annum (tpa) of lithium carbonate equivalent. They believe the project holds greater potential to deliver superior returns for shareholders.

Read the full study here.

Click here to connect with Galan Lithium (ASX:GLN) for an Investor Presentation

This post appeared first on investingnews.com

previous post
Global scam industry evolving at ‘unprecedented scale’ despite recent crackdown
next post
Top 7 Global Lithium Stocks in 2025

Related Posts

C29 Signs Binding HOA to Drive Growth

May 5, 2025

Greenvale to Commence Alpha Test Program 7

May 2, 2025

Crypto Market Recap: Trump’s Crypto Moves Stir ECB...

February 8, 2025

Extension of Takeover Offer Period

March 21, 2025

Josef Schachter: Oil to US$80 by Q4? Plus...

May 24, 2025

Top 5 Canadian Lithium Stocks of 2025

March 27, 2025

Crypto Market Recap: Bitcoin Breaks US$100,000 as ETF...

May 10, 2025

Syntheia Signs Maiden Enterprise Deal with Van-Fort Ontario

February 21, 2025

SPUT’s US$200 Million Uranium Buying Plan Spurs Market...

June 18, 2025

EU Deems Mkango and Euro Manganese Projects “Strategic”...

March 27, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 2

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 3

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 4

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 5

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 6

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • 7

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 wallstreetwizardry.com | All Rights Reserved